Skip to content

Alkermes

US · ALKS #1780 by market cap Listed 1970
44.94 -1.24 -2.69%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Price chart

Pre-market 46.18 0.00%
After-hours 45.50 +1.25%
55.2237.3544.942026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on ALKS?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +26.5% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days B → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall A+

The radar needs all six factors. Available grades are shown below.

Valuation N/A

How expensive the stock is versus earnings, sales and its own 5-year history.

Not enough data to grade this factor.

Growth A

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 9.9% Better than 64%
Net income CAGR (3Y) 224.5% Better than 99%
Free cash flow CAGR (3Y) 77.4% Better than 90%
Profitability A-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 86.7% Better than 94%
Operating margin 17.2% Better than 70%
Net margin 16.4% Better than 74%
Return on equity 14.7% Better than 67%
Return on invested capital 12.5% Better than 77%
Momentum A-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -7.0% Better than 58%
6-month return 22.1% Better than 85%
12-month return (ex latest month) 52.5% Better than 84%
Distance below 52-week high 19.3% Better than 62%
Financial Health A+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 3.5x Better than 78%
Debt to assets 2.8% Better than 85%
Interest coverage 24.7x Better than 85%
Free cash flow / net income 198.8% Better than 77%
Analyst View B-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 69.2% Better than 48%
Upside to average target 37.4% Better than 57%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -4.44%
1M +1.88%
3M -6.41%
6M +21.53%
YTD +60.61%
1Y +59.42%
3Y +85.86%
5Y +93.37%

Key statistics

Price & volume

Prev close
46.18
Open
45.79
Day range
44.83 - 46.89
Avg price
45.43
Volume
1.08M
Turnover
49.10M
Amplitude
4.46%
52-week range
27.00 - 55.67

Valuation

P/E
31.43
P/E (TTM)
-4,494.00
P/B
4.05
EPS
1.43
Net profit
240.30M
Net assets
1.86B

Share structure

Market cap
7.55B
Float cap
6.99B
Shares out
168.04M
Float shares
155.48M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 63% of range
27.00 55.67

19.3% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-52.66M net over the window

Short interest

Shares short
19.65M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Alkermes (ALKS)?

Alkermes last traded at 44.94. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Alkermes's market cap?

About 7.55B.

What is the P/E ratio of Alkermes?

The trailing twelve-month P/E is -4,494.00. The Valuation tab shows it against the stock's own five-year range.

Does Alkermes pay a dividend?

Alkermes does not currently pay a regular dividend.

Is Alkermes a buy according to analysts?

The consensus of 13 analysts is a Buy rating, with an average 12-month price target of 61.73, which implies 37.4% upside from the current price. This is not investment advice.

What is Alkermes's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Alkermes a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:01:09 · For reference only, not investment advice and not tailored to your situation.

Alkermes discussion 0 comments

Add a comment